Chris Kaplan BS, MS, PhD

Dr. Kaplan began his career working on targeted antimicrobials and helped advance a lead candidate through a successful IND. His contributions included developing a companion diagnostic deployed in clinical trials. Dr. Kaplan assumed a central role clinical trial design and clinical microbiology as the product advanced through phase 2. Dr. Kaplan deploys that broad experience in this current role leading the product development group which is establishing non-clinical and process development methodologies to bring industry leading drug development standards to phage therapeutics.